Clinical microbiology services are essential for diagnosis, treatment and prevention of MRSA and other nosocomial pathogens in Libyan healthcare facilities

Libyan Journal of Medicine

Volumn 4, Issue 3, 2009, Pages 91-92

  El Bouri, K W ^a  

^a SINGLETON HOSPITAL   (United Kingdom)

Author keywords

Libya; MRSA; Nosocomial infection

Indexed keywords

CLINDAMYCIN; DAPTOMYCIN; ERYTHROMYCIN; LINEZOLID; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

BURN INFECTION; CLINICAL ASSESSMENT; CLOSTRIDIUM DIFFICILE; EDITORIAL; HEALTH CARE FACILITY; HOSPITAL INFECTION; HUMAN; LIBYAN ARAB JAMAHIRIYA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 75249104496     PISSN: 19932820     EISSN: 18196357     Source Type: Journal    
DOI: 10.3402/ljm.v4i3.4820     Document Type: Editorial

References (8)

1. Zorgani A, Shawerf O, Tawil K, El-Turki E, Ghenghesh KS. Inducible Clindamycin Resistance among Staphylococci Isolated from Burn Patients. Libyan J Med. 2009; 4: doi:10.4176/090128.
2. Yilmaz G, Aydin K, Iskender S, Caylan R, and Koksal I. Detection and prevalence of inducible clindamycin resistance in staphylococci. Journal of Medical Microbiology 2007; 56: 342-45.
3. Angel MR, Balaji V, Prakash JAJ, Brahmadathan KN, and Mathews MS. Prevalnce of inducible clindamycin resistance in gram positive organisms in a tertiary care centre. Indian Journal of Medical Microbiology 2008; 26: 262-64.
4. Laplante KL, Leonard SN, Andes DR, Craig WA, and Rybak MJ. Activities of clindamycin, daptomycin, doxycycline, trimethoprim-sulphamethoxazole, and vancomycin against community-acquired methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models. Antimicrobial Agents and Chemotherapy 2008; 52: 2156-2162.
5. Pettet D, Allegranzi B, Storr J, Bagheri Nejad S, Dziekan G, Leotakos A and Donaldson L. Infection control as a major World Health Organisation priority for developing countries. Journal of Hospital Infection 2008;68:285-92
6. Petti CA, Polage C, Quinn CT, Ronald AR, and Sande MA. Laboratory medicine in Africa: a barrier to effective healthcare. Clinical Infectious Diseases 2006; 42: 377-82..
7. Wilcox MH, Cunniffe JG, Trundle C and Redpath C. Financial burdens of hospital-acquired Clostridium difficile infection. Journal of Hospital Infection 1996; 34: 23-30.
8. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, and Farr BM. SHEA guideline for preventing nosocomial transmission of multi-resistant strains of Staphylococcus aureus and Enterococcus. Infection Control and Hospital Epidemiology 2003; 24:362-86.